PPT-Training for Providers on the Use of Oral Pre-exposure Prophylaxis for the Prevention

Facilitator Background Materials Review these slides prior to using these materials Introduction to Training Materials These training materials May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. Dr.. Rachel Baggaley, HIV dept. WHO, Geneva. GNP+ . WEBINAR: What does PrEP mean for. people living with HIV: science, policy. and . implementation?. . Date: Thursday, 30th July 2015. Time: 4pm CET. PrEP Information Sheet Pre-exposure Prophylaxis (PrEP) for HIV Prevention Frequently Asked Questions What is PrEP? “PrEP” stands for preexposure prophylaxis. The word “prophylaxis” PrEP. ). Yuma Health District 5/23/16. Alyssa Guido, MPH. Program Director, Arizona AETC. Arizona AIDS Education and Training Center. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under . Kevin L. Ard, MD, MPH. October 20, 2016. Learning objectives. Summarize the indications for and management of pre- and post-exposure prophylaxis. Understand clinical uncertainties in pre-exposure prophylaxis management. Efficacy and the importance of adherence. Joanne . Stekler. , MD MPH. August 20, 2015. Key HIV . PrEP. Trials Using Oral . Tenofovir. (TDF) or . Tenofovir-Emtricitabine. (TDF-FTC). Study. Study Population. Integrating Pre-Exposure Prophylaxis ( PrEP ) into the Primary Care Setting Christine Kerr, MD Medical Director of HIV, Hepatitis, and Specialty Care Hudson River HealthCare February 12, 2016 Why Knowledge Just over three-quarters of providers were familiar with oral PrEP, while 23% had not heard of it (Figure 2). The most common sources of information were the national guidelines/policy and other healthcare workers. Zindoga. Mukandavire. 1. , . Graham F. Medley. 1. , Fern Terris-Prestholt. 1. ,. . Daniel J. Klein. 2. , Anna Bershteyn. 2. , Katharine Kripke. 3. , Joseph Murungu. 4. , . Definate. Nhamo. 4. ,. . 1of 2PageCreated 9/2019ecommendations for Persons Exposed to MeaslesaIG can be administered intramuscularly IGIM or intravenously IGIV Please check references available at https//wwwcdcgov/measles/ind NURS RESEARCH POROJECT PROPOSA. NURS 503. Name:…………. Ana G Mendez University. Facilitator: Nancy Woelki . DNP, APRN, MSN, RN. Date:………... The purpose of this research was to evaluate the advantage and disadvantage using of PrEP for HIV-negative adults with high risk for HIV.. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . Courses in Therapeutics and Disease State Management. Learning Objectives (Slide 1 of 3). Differentiate between influenza A and influenza B. List the primary subtypes of influenza A that are currently circulating. , PEP, PREP . Compiled by Jason Vermaak, . Ektha. . govind. and . Anjana. Thomas. Opportunistic infection In HIV. Opportunistic infections are those that occur more frequently in immunocompromised populations and are often more clinically severe in this group of people.. PrEP. ) in a public family planning facility and youth center to inform national roll out in Zimbabwe. 22. nd. International . AIDS Conference. 24 July 2018. Presented by Makaita Gombe, Clinton Health Access Initiative (CHAI).